User:Mr. Ibrahem/Abciximab

Abciximab, sold under the trade name Reopro, is a medication used around the time of percutaneous coronary angioplasty (PCI). It is given by injection into a vein. Full onset occurs within 10 minutes and lasts up to 48 hours after it is stopped.

Common side effects include bleeding, low blood pressure, nausea, headache, and peripheral swelling. Other side effects may include anaphylaxis and low platelets. Safety in pregnancy is unclear. It a glycoprotein_IIb/IIIa inhibitor which works by preventing platelets from sticking together.

Abciximab was approved for medical use in the United States in 1994. In the United States 10 mg costs about 1,300 USD as of 2022.